This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Xenothera. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Odile Duvaux: Innovator in Antibody Production
Introduction
Odile Duvaux is a prominent inventor based in Nantes, France. She has made significant contributions to the field of biotechnology, particularly in the production of polyclonal antibodies. Her innovative work has the potential to impact medical treatments and therapeutic applications.
Latest Patents
Odile Duvaux holds a patent for a "Method for producing polyclonal antibodies with improved complement-dependent cytotoxicity." This invention relates to polyclonal antibodies directed against non-human biological pathogens or molecules derived from these pathogens. The antibodies are designed to be devoid of specific antigenic determinants, such as N-glycolneuraminic acid (Neu5Gc) and a-1,3-galactose, enhancing their use as a medicament.
Career Highlights
Duvaux is currently associated with Xenothera, a company focused on developing innovative therapies. Her work at Xenothera emphasizes the importance of her research in advancing medical science and improving patient outcomes.
Collaborations
One of her notable collaborators is Jean-Paul Soulillou, with whom she has worked closely in her research endeavors. Their partnership highlights the collaborative nature of scientific innovation.
Conclusion
Odile Duvaux's contributions to the field of biotechnology, particularly in antibody production, showcase her innovative spirit and dedication to advancing medical science. Her work continues to pave the way for new therapeutic possibilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile